Suppressive effect of chrysin on macrophage LC3B autophagy through miR-204-5p in diabetic atherosclerosis Authors: Chiu-Mei Lin, Bao-Wei Wang, Wei-Jen Fang, Chun-Ming Pan, Kou-Gi Shyu Published: 2026 ABSTRACT Flavonoid chrysin possesses many biological properties. Autophagy and inflammation interact to cause diabetic cardiovascular diseases. However, whether chrysin affects macrophage autophagy and microRNA 204-5p regulation under hyperglycemic conditions remain unclear. In this study, we examined that the effects of chrysin on the molecular regulatory mechanisms of miR-204-5p in LC3B macrophage autophagy under hyperglycemic stimulation. Macrophages were cultured with 25 mM glucose for hyperglycemia stimulation. A diabetic rat model of carotid artery balloon injury was established. Reverse transcription and real-time quantitative polymerase chain reaction, Western blotting, immunohistochemical staining, and luciferase activity assay were performed. The results indicated that chrysin augmented the macrophage autophagy marker LC3B presentation under high-glucose (HG)-stimulation significantly, however, chrysin attenuated the miR-204-5p level in macrophage cultures. Treatment with chrysin, rapamycin or mutant miR-204-5p increased LC3B presentation through the suppression of miR-204-5p level in macrophage cultures under HG-stimulated condition. By luciferase activity assay, the combination of chrysin with mutant miR-204-5p reduced LC3B binding activity under hyperglycemic stress. Treatment with chrysin (100 mg/kg/day) and wild-type miR-204-5p considerably reduced the neointimal sizes by 46.3% and 36.3%, respectively, at 14 days after carotid artery balloon injury in STZ-induced diabetic rats; ameliorated M1 polarization simultaneously. However, by treating with chrysin suppressed LC3B presentation in diabetic rats. Our findings indicate, under hyperglycemic stress, chrysin regulates the presentation of LC3B autophagy in hyperglycemia-stimulated macrophage cultures and neointimal hyperplasia by mediating the miR-204-5p expression. The results imply that chrysin is potentially effective for preventing hyperglycemia related cardiovascular diseases.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-026-50719-4. Introduction Evidence suggests that diabetes is associated with mortality from atherosclerosis, coronary heart disease, or heart failure1. Atherosclerosis is regarded with increasing the levels of inflammatory cytokines and results in the thickening of intimal layer, accumulation of foam cells, and formation of atheromatous plaques in large- and medium-sized arteries. Autophagy involves the delivery of cytoplasmic substrates to lysosomes for degradation, a process that plays a key role in maintaining cellular metabolic homeostasis2. Accumulating evidence suggests that impaired autophagy induced by metabolic syndrome is related to oxidative stress, and inflammation, further promoting atherosclerosis3. Inflammation and autophagy interact to cause cardiovascular diseases (CVDs), with macrophage autophagy playing a functional role in atherosclerosis, myocardial infarction, and cardiac remodeling4. Therefore, exploring the correlation between macrophages and autophagy in cardiac diseases is crucial4. MicroRNAs (miRNAs) are small non-coding RNAs with their functional diversity and expression specificity. Few studies have explored the role of miRNAs in monocyte differentiation and macrophage activation under hyperglycemic condition1. Tian et al.5 reported that endothelial autophagy had a protective effect against atherosclerosis through the transfer exosomal miR-204-5p from endothelial cells to smooth muscle cells. Qi et al.6 indicated that miR-520a-3p promoted the development of atherosclerosis in mice and reduced IL-4/IL-13-induced macrophage autophagy by targeting ultraviolet radiation resistance-associated gene6. Notably, miR-204-5p is a highly tissue-specific miRNA, with measurable levels in kidney and arteries, and plays a crucial role in molecular regulatory mechanisms and the development of pathophysiological or diabetic conditions7,8. LC3B is a central RNA-binding protein that causes rapid mRNA degradation during autophagy9. Despite these findings, the molecular regulatory effects of miR-204-5p on macrophage autophagy in diabetic atherosclerosis remain unclear. Few investigations indicate that herb or plant regulates autophagy in cardiovascular diseases through mediating microRNAs. Chen et al.10 reported that tanshinone IIA activated KLF4 and promoted autophagy to alleviate atherosclerosis through the polarization of macrophages and inhibiting miR-375. Wang et al.11 indicated that astragaloside IV (the main active compound of traditional Chinese medicinal herb, Astragalus membranaceus) mitigated miRNA-1-mediated inflammation and autophagy in the heart tissue of rats and H9C2 cells treated with lipopolysaccharides. Chrysin is a natural and biologically active flavonoid (5,7-dihydroxyflavone), found in various vegetables and medical plants. It has many bioactive activities, including antiinflammation, and antiapoptosis12. Chrysin reduces the blood glucose and cholesterol levels and is involved in the regulation of diabetic cardiovascular diseases12. In the previous study, we reported that chrysin upregulates the expression of Krüppel-like factor 2 (KLF2) expression by suppressing endothelial cell-derived exosomal microRNA-92a in the model of atheroprotection13. He et al.14 examined the microenvironmental regulation of miRNAs for autophagy and reported that chrysin induced autophagy and apoptosis in endometrial cancer cells through the inactivation of the ROS-mediated Akt/mTOR signaling pathway14. However, few studies have examined the regulatory effects of chrysin on macrophage autophagy through miRNAs in diabetic atherosclerosis. Therefore, in this study, we explored the molecular regulation of chrysin on autophagy in hyperglycemic macrophage cultures to mimic the diabetic CVDs. Our results confirmed the efficacy of chrysin in preventing hyperglycemia related cardiac diseases. Materials and methods Chemical reagents High purity (≥ 96%) of chrysin was purchased from Sigma-Aldrich. Dulbecco’s modified Eagle’s medium was purchased from GIBCO (Life Technologies). Dimethyl sulfoxide was obtained from Sigma-Aldrich. Penicillin and streptomycin were obtained from GIBCO. Chrysin was dissolved with DMSO (less than 1:1000 concentration), and storage in the concentration of 50 mM for in vitro assay. Streptozotocin (STZ)-induced diabetic rat model Male Wistar rats (220–250 g, aged 15 weeks) purchased from BioLASC (BioLASC Taiwan Co., Ltd., Taipei, Taiwan), were maintained under normal conditions, with free access to water and stander food. The standard operating procedure (SOP) for anesthesia/humane endpoint/tissue harvesting: (a) anesthesia induction and maintenance: Inhalation anesthesia will be performed using isoflurane delivered via a VIP 3000™ Veterinary Anesthesia Vaporizer (Matrx). (1) induction: Rats will be placed in an induction chamber with 4%–5% isoflurane and an oxygen flow rate of 1.0–1.5 L/min. (2) tracheostomy and intubation: Once the righting reflex is lost, a tracheostomy will be performed for intubation. The rat will be immediately connected to a SAR-830/AP ventilator (CWE Incorporated). (3) ventilation parameters: For a rat weighing approximately 310 g, the tidal volume (Vt) will be set at 2.6 ml, and the respiratory rate (RR) will be maintained at 60–70 breaths/min to ensure physiological stability during open-chest procedures. (4) monitoring: The depth of anesthesia will be monitored every 5 min using the pedal reflex (toe pinch) to ensure the animal remains in a surgical plane of anesthesia without pain perception. (b) humane endpoint and sampling procedures: Upon reaching the humane endpoint, the following anesthetic overdose and tissue harvesting procedures will be executed: (1) anesthetic overdose: Prior to performing the thoracotomy (1–2 min before incision), the isoflurane concentration will be increased to 5% to induce deep central nervous system depression and anesthetic overdose. (2) thoracotomy and cardiac puncture: After confirming a total lack of response to painful stimuli, a midline thoracotomy will be performed. While the heart is still beating under deep anesthesia, blood will be collected via cardiac puncture from the left ventricle using a 23G needle. (3) tissue harvesting: Following blood collection, the heart will be removed (excision of the heart) for preservation. Subsequently, the carotid artery segment previously subjected to balloon injury will be carefully dissected and harvested. (c) verification of death: Death will be confirmed by observing the permanent cessation of heartbeat and respiration, dilation of pupils, and blanching of mucous membranes. An STZ-induced diabetic rat model was performed as previously described were injected with the different intraperitoneal injection of streptozotocin at the range of 30–120 mg/kg (STZ, Sigma, St. Louis, MO, USA) to become diabetic condition13,15. At 7 days after diabetic induction, blood samples were collected from the tail veins and assayed using the glucometer. Diabetes was confirmed through the detection of hyperglycemia (19.4 mM) for at least 1 week. All animal procedures are performed in accordance with institutional guideline and conformed to Guide for the Care and Use of Laboratory Animals, published by the United States National Institutes of Health (NIH publication No. 86 − 23. Revised 2011). Macrophage culture in glucose RAW264.7 macrophages derived from Mus musculus were obtained from American Type Culture Collection (ATCC), cultured in DMEM (Thermo Fisher Scientific) supplemented with 10% fetal bovine serum (Gibco) at 37˚C with 5% CO2. Subsequently, they were cultured in 100-mm dishes containing a cell growth medium with glucose concentrations ranging from 5.5 mM to 100 mM (divided into five groups). Given that 25 mM high glucose (HG) has a major effect on miR-204-5p mRNA level, this concentration was used in the subsequent experiments. The animal experimental design is reported in accordance with ARRIVE guidelines (Supplementary data 1). Western blot analysis Western blotting was performed as previously described13 by using mouse anti-LC3B monoclonal antibody (Santa Cruz Biotechnology). Signals were visualized through chemiluminescence. All western blot analyses were quantified using densitometry. PCR product construction and sequencing PCR product cloning was performed using a pGEM®-T Easy Vector System (Promega, Madison, WI, USA). Ligation was performed in a final reaction volume of 10 µL consisting of 5 µL of 2x Rapid Ligation Buffer, 1 µL of pGEM®-T or pGEM®-T Easy Vector (50 ng), 1 µL of T4 DNA Ligase, and 3 µL of PCR products. The PCR procedure was performed as previously described16. The primers used for direct sequencing reactions were identical to those used in the amplification reactions. The nucleotide sequences of both strands were determined with an ABI 3730 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) equipped with a long-read sequencing capillary and a POP-7 sequencing polymer. Real-time reverse transcription-polymerase chain reaction Total RNA was extracted from the cultured macrophages following the single-step acid guanidinium thiocyanate–phenol–chloroform extraction method. Real-time reverse-transcription polymerase chain reaction was performed as described previously16. The mouse LC3B primers were 5′-TCC CAT CGA AGT GTA CGA-3′ (forward) and 5′-AAG ATC CCT TTT TGC CTT GGT A-3′(reverse). Protein-coding region of LC3B construction and luciferase activity assay Partial mouse protein-coding region of LC3B (containing miR-204-5p binding site), ENSMUST00000172812.2 _267–766 bp; Chromosome 19:5,795,690-5,802,672; http://www.ensembl.org/index.html was generated by artificial synthesis, digested with SacI and Xbal restriction enzymes, and ligated into the pmirNanoGLO plasmid vector (Promega). The cloned mouse LC3B-II DNA fragment contained miR-204-5p potential binding sites (from 387 to 408 bp). For the mutant, the conserved site AGGCCCAGGTTGCCTAGCAGA was mutated into CTTACCCTTTGTCATCGCATC and constructed using the same method described above. All cloned plasmids were confirmed by DNA sequencing (Seeing Bioscience Co., Ltd., Taipei, Taiwan). The luciferase assay procedure was performed as previously described16. The test plasmid (2 µg) was transfected by ViaFect™ Transfection Reagent (Promega) in accordance with the manufacturer’s protocol. Briefly, the mixture of transfection reagent and DNA was incubated for 20 min at room temperature. Subsequently, it was added to cell culture medium for 24 h, and then replaced with a normal culture medium. After treatment, cell extracts were prepared using the Nano-Glo dual-luciferase reporter assay system (Promega) and quantified for luciferase activity by using a luminometer (Glomax Multi Detection System, Promega, Madison, WI, USA). Carotid artery balloon injury Animal experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of Shin Kong Wu Ho-Su Memorial Hospital (113SKH008, 2024). Male Wistar rats (weighing 300–310 g) were randomly assigned to the experimental groups. Chrysin was administered at a dose of 100 mg/kg body weight once daily via oral gavage. The dosage was adjusted according to the most recent body weight of each animal to ensure precise administration. The vehicle control group received an equivalent volume of 0.5% (w/v) carboxymethylcellulose sodium (CMC-Na) solution. Adult Wistar rats were anaesthetized with isoflurane (3%) and subjected to balloon catheter injury of the right carotid artery, as described previously13. Histological and immunofluorescence staining Histological and immunofluorescence staining were performed as described previously13. Briefly, tissue sections were harvested, placed overnight in 4% paraformaldehyde, and subsequently embedded in paraffin. After the sections were cut to a thickness of 5 μm, they were incubated with primary antibody at 4 °C for 12 h. Subsequently, the sections were washed three times with PBS and then incubated for 1–2 h at room temperature in the darkness with fluorescence-conjugated secondary antibody in PBS. Next, the nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI). A coverslip was mounted, the sections were examined under a fluorescence microscopy. Each section was examined in at least three random fields. Statistical analysis Data were expressed as the mean ± SD of three replicates from four separate experiments. Statistical significance was determined through an analysis of variance (ANOVA; GraphPad Software). Dunnett’s test was used to compare multiple groups with a single control group. Pairwise comparisons among multiple groups were conducted using ANOVA followed by a Tukey–Kramer comparison test. A value of P < 0.05 was considered to be statistically significant. Results Effect of chrysin on miR-204-5p and LC3B expression in cultured mouse macrophages under hyperglycemic stress conditions Treatment with high glucose (25 mM, HG)-stimulated chrysin reduced miR-204-5p level in the tendency of concentration manners (Fig. 1A). Cell viability assays are used to measure the treatment of chrysin in macrophage cultures under hyperglycemia stress (Supplementary data 2). In the model of hyperglycemic stress, treatment of cultured macrophages with the HG and chrysin (10− 6M), significantly increased cytoplasmic miR-204-5p levels in time-dependent manners (Fig. 1B), but not low glucose (LG, 10 mM) (data not shown). By treating with chrysin (10− 6M) increased the expression of LC3B mRNA and protein levels in HG (25 mM)-cultured mouse macrophages in a time-dependent manner (Fig. 1C and D). Additionally, the protein presentation of LC3B II/I ratio revealed consistently (data not shown). Molecular regulation of chrysin, LC3B autophagy marker, or miR-204-5p in hyperglycemic macrophage cultures To test the molecular regulatory mechanism of macrophage autophagy, the augmenting LC3B mRNA level was observed by treatment with chrysin (10− 6M), rapamycin (mTOR, Sigma-Aldrich, Saint Louis, MO, USA; an autophagy inducer) and mutant miR-204-5p after 6 h under HG-stimulation (25 mM); but the LC3B mRNA levels were reduced by treatment with wild type miR-204-5p or 3-methyladenine (3-MA, Sigma-Aldrich, Saint Louis, MO, USA; an autophagy inhibitor) (Fig. 2A). As presented in Fig. 2B, treated with rapamycin, chrysin (10− 6M), and mutant miR-204-5p significantly increased LC3B protein, but wild type miR-204-5p or 3-methyladenine present the similar expression of the LC3B protein as compared to control (Fig. 2B). Effects of miR-204-5p and chrysin on the luciferase activity of LC3B in macrophages under hyperglycemic stress conditions In previous study, we discovered a binding site for miR-204-5p in the 3′UTR of LC3B (387–408 bp)16. Figure 3 illustrates the sequence of the LC3B 3′UTR target site for miR-204-5p binding (387–408 bp) with under HG stimulation condition. When miR-204-5p was bound to the normal LC3B 3′UTR, miR-204-5p overexpression significantly decreased the luciferase activity of LC3B in macrophages stimulated by HG (25 mM; Fig. 3, upper panel). Mutant miR-204-5p overexpression did not significantly affect the luciferase activity of LC3B, indicating that the target of LC3B was miR-204-5p. When miR-204-5p was bound to the normal LC3B 3′UTR, the combination of chrysin (10− 6M) and miR-204-5p significantly decreased the luciferase activity of LC3B in macrophages stimulated by HG (25 mM; Fig. 3, lower panel). Molecular regulation effects of chrysin on miR-204-5p after carotid artery balloon injury in diabetic rats The model of diabetic rats after carotid artery balloon injury was designed to mimic the diabetic atherosclerotic condition. To determine the effect of chrysin and miR-204-5p on LC3B expression and neointimal hyperplasia, diabetic rats stimulated by streptozotocin (STZ, 90 mg/kg), were subjected to carotid artery balloon injury. The results indicated that chrysin significantly reduced the levels of glucose in this model (Fig. 4A, lower panel). The levels of miR-204-5p mRNA significantly decreased from 3 to 28 days after carotid balloon injury in diabetic rats (Fig. 4B). In addition, the mRNA levels of LC3B in the arterial tissue of the carotid artery gradually increased from 3 to 28 days in diabetic rats. However, the levels of miR-204-5p suppressed significantly (Fig. 4C). Because LC3B is involved in the molecular regulation of autophagy under hyperglycemic stimulation conditions5, we investigated the effects of chrysin or mutant miR-204-5p on the expression of LC3B and miR-204-5p in rats. The results indicated that treatment with chrysin and miR-204-5p significantly attenuated LC3B mRNA and protein expression at 14 days after carotid artery balloon injury in diabetic rats (Fig. 4D and E). Measurement of neointimal formation and lumen sizes and immunohistochemical staining of LC3B for the effects of chrysin and miR-204-5p in STZ-induced rats After 2 weeks of carotid artery balloon injury, the neointimal hyperplasia significantly increased and caused the narrowing of the vascular lumen in STZ (90 mg/kg)-treated rats. Immunohistochemical staining revealed high LC3B expression levels in intimal layer at 14 days after carotid artery balloon injury in diabetic rats under STZ-induced hyperglycemic conditions (Fig. 5). The fluorescence signals corresponding to LC3B also increased in the arterial tissue at 14 days after carotid artery balloon injury in diabetic rats. Treatment with chrysin and miR-204-5p significantly downregulated the expression of LC3B expression in the intimal area (Fig. 5A, right panel). In addition, treatment with chrysin (100 mg/kg/day) and miR-204-5p ameliorated the neointimal hyperplasia in diabetic rats with carotid artery balloon injury (Fig. 5A, left panel). By treating with chrysin (100 mg/kg/day), miR-204-5p wild-type and mutant miR-204-5p dominant considerably increased luminal sizes, but reduced the neointimal formation by 46.3%, 36.3% and − 5.1%, respectively, at 14 days after carotid artery balloon injury in STZ-stimulated rats (Fig. 5B, lower panel). At the intimal layer, the results of immunohistochemical staining and immunofluorescent analysis strongly indicated the suppression of LC3B expression in the rat carotid artery of STZ-induced hyperglycemia stress after 14 days of balloon injury (Fig. 5C). Although the classical polarized M1/M2 oversimplifies macrophage heterogeneity, it remains a valuable framework for interpreting their functional roles in metabolic diseases17. The polarized M1/M2 macrophages revealed M1/CD86 and M2/CD163 markers by immunofluorescent analysis in the rat carotid artery of STZ-induced hyperglycemia stress after 14 days of balloon injury, treatment with chrysin and miR-204-5p wild-type ameliorated the M1 polarization (Fig. 5D). Discussion Studies suggest natural compounds, such as curcumin, berberine, and catalpol, can be used as therapeutic agents for diabetic CVDs18. Chrysin exerts an antiinflammatory effect on cardiometabolic disorders by targeting different mechanisms of insulin signaling stimulation and modulating different apoptotic and autophagic signaling pathways19. Propolis and chrysin have antidyslipidemic, antiatherosclerotic, and antidiabetic effects, mediated by antioxidant and antiinflammatory effects20. Few studies have elucidated the molecular regulatory effects of natural products or phytochemicals on macrophage autophagy in diabetic cardiovascular rat models. To the best of our knowledge, this is the first study to reveal that chrysin regulates LC3B macrophage autophagy through the suppression of miR-204-5p expression and that chrysin attenuates neointimal hyperplasia in rats with STZ-induced hyperglycemia and carotid artery balloon injury, for mimicking the application of clinic percutaneous coronary intervention (PCI) in diabetic atherosclerotic patients. Our findings revealed different presentations of LC3B and miR-204-5p regulatory phenomena (Figs. 1 and 5) between HG-stimulated macrophage and rat STZ-induced diabetes after carotid artery balloon injury. These findings were speculated the ability of autophagy hemostasis to prevent the development of atherosclerosis. Yao et al.21 examined and determined that oral administration of chrysin (5000 mg/kg) showed 40% mortality in Sprague Dawley rats for the chrysin toxicologic investigation. Rani et al.22 reported that pretreatment with oral feeding chrysin (60 mg/kg) significantly ameliorated ischemia/reperfusion-induced myocardial ischemia in STZ-induced (70 mg/kg, intraperitoneal injection) diabetic rats through increasing PPAR-γ/Nrf2 and decreased RAGE (receptor for Advanced glycation end products) protein expression22. Our study model of the diabetic artery balloon injury in Wistar rats, the administration of chrysin (100 mg/kg) was reflected the previous toxicologic evaluation. Furthermore, Pitchakarn et al.23 tested that the safety and anti-genotoxicity properties of chrysin through multi-biological models, and reported no killing effect on 3T3-L1 (adipocytes), RAW 264.7 (macrophages), HEK293 (kidney cells), and LX-2 (hepatic stellate cells); Wang et al.24 documented that supplement of gingerol-enriched ginger increased the antioxidant capacity (SOD1), but decreased the gene expression for mitochondrial fusion (MFN1), mitophagy (LC3B, P62, PINK1), and inflammation (NF-κB) on intestinal health in 4-week-feeding diabetic rats. Supplement of high-dose 69 µg 25-hydroxycholecalciferol (25-OH-D3)/kg alleviated cardiac fibrosis and autophagy through the suppression of microtubule-associated protein 1 light Chain 3 beta (LC3B), and further demonstrated consistently decreased circulating and cardiac IL-6 and IL-1β levels in broiler breeder hens25. Our previous study13 and present findings are consistent with the macrophage autophagy modulation without striking toxicity in different conditions. Recent growing evidence has revealed the critical roles of autophagy and macrophages in the progression and potential treatment of atherosclerosis, different cellular compounds and regulatory mechanisms26. Wang et al. reported that tetrahydropalmatine upregulated autophagy markers p-AMPK/AMPK and LC3-II/LC3-I, and increased Beclin-1 mRNA expression, but decreased MCP-1 mRNA expression in high-fat diet apolipoprotein E-deficient mice and ox-LDL-induced RAW264.7 cells27. The delivery of exosome-mediated miR-204-5p promotes endothelial autophagy of atheroprotective communication between endothelial and smooth muscle cells5. Wang et al.28 showed that Guanxinning tablet (Chinese medicinal formula) enhanced human umbilical vein endothelial cell migration and upregulated autophagy-related proteins (Beclin1, LC3A, and LC3B). Furthermore, Yan et al.29 reported the butyrate (a metabolite of intestinal flora) inhibited the inflammatory response of human monocyte-macrophages (THP-1 cells) induced by high glucose and the damage of pancreatic and renal tissue in diabetic mice through the suppression of Beclin-1and LC3B29. Our present findings are suggested the effect of chrysin on autophagy through LC3B and miR-204-5p modulation, meanwhile, in hyperglycemia-induced macrophage cultures and in rat diabetic balloon-injured arteries. Rat models with STZ-induced diabetes have been widely used to stimulate hyperglycemic conditions. Salama et al.30 reported that chrysin ameliorated STZ-induced diabetes in rats by increasing the levels of insulin and pancreatic GLUT2 levels and activating the TLR4/NF-κβ/HSP70 inflammatory pathways. Singh et al.31 discovered that pretreatment with chrysin (60 mg/kg) mitigated the effect of ischemic preconditioning condition and ameliorated the myocardial infarction through the PI3K-Akt-eNOS signaling pathway in STZ-induced diabetic rats with ischemia/reperfusion injury. Despite these findings, few studies have examined neointimal hyperplasia in rats with STZ-induced hyperglycemia. In this study, our data suggest that oral treatment with chrysin ameliorates neointima (46.3%) and increases lumen size (63.0%) after 2 weeks of carotid artery balloon injury in rats with STZ-induced hyperglycemia. They also suggest that autophagy plays a key role the cellular catabolic process responsible for cellular defense, including macrophage and vascular smooth cells and for maintaining the stability of atherosclerotic plaques2. Xu et al.32 argued that natural plant products and phytochemicals are promising modulators of autophagy against noncommunicatable diseases, such as CVDs, cancer, and diabetes. Abd El-Emam et al.33 examined a rat model of alloxan-induced diabetic neuropathy and reported that chrysin-loaded PEGylated liposomes decreased the levels of blood sugar, upregulated the expression of miR-301a-5p, and increased the expression of autophagic markers. Foussard et al.34 reported that ICAM1 expression by the microvasculature impairs ischemic muscle reperfusion in HFD + STZ mice34. Furthermore, Ouerd et al.35 showed that endothelium ET-1 overexpression enhanced the progression of atherosclerosis, perivascular oxidative stress, and inflammation through NOX1 in Apoe-/- and eET-1/Apoe-/- mice35, Taberner-Cortés et al.36 exhibited that treatment with SGLT2i dapagliflozin (DAPA) was not seen the changes in lesion size, vulnerability or content of macrophages, vascular smooth muscle cells, T cells or collagen in the metabolism and atherosclerosis in Apoe-/-Irs2+/- mice36. Mittal et al. reviewed that target hypoxia revealed the interplay between hypoxia, hyperglycemia, and immune responses to result in the functional vascular dysfunction or impaired vascular permeability or mitochondria damage or apoptosis by modulating the inflammatory reaction; this concept may direct the future development to elucidate the complexity of atherosclerotic process and the regulation of diabetic condition through the interaction of inflammation and vascular dysfunction in various cells37. In diabetic macrovascular complications, M1 macrophages localize predominantly to the necrotic core, whereas M2 macrophages are enriched in regions of neovascularization15. Therefore, in our study, treatment with chrysin and miR-204-5p mitigated neointimal hyperplasia, M1 polarization and downregulated the expression of LC3B in macrophage autophagy, indicating the key role of miR-204-5p in atherosclerotic process. Fig. 1Effect of chrysin on miR-204-5p and LC3B mRNA expression in cultured mouse macrophages under hyperglycemic stress conditions. (A) Concentration-tendency effects of treatment with chrysin on cytoplasmic miR-204-5p mRNA levels in mouse macrophages stimulated with the high glucose (25 mM, HG). (B) Time-dependent effects of treatment with chrysin (10−6M) on cytoplasmic miR-204-5p mRNA levels in the HG-cultured mouse macrophages. (C) Chrysin upregulated the expression of LC3B mRNA level after stimulation with HG in a concentration-dependent manner. (D) Time-dependent effects of treatment with chrysin (10−6M) on LC3B protein presentation in the HG-cultured mouse macrophages. *P < 0.05 versus control group (three iterations per experiment, N = 4). Effect of chrysin on miR-204-5p and LC3B mRNA expression in cultured mouse macrophages under hyperglycemic stress conditions. (A) Concentration-tendency effects of treatment with chrysin on cytoplasmic miR-204-5p mRNA levels in mouse macrophages stimulated with the high glucose (25 mM, HG). (B) Time-dependent effects of treatment with chrysin (10−6M) on cytoplasmic miR-204-5p mRNA levels in the HG-cultured mouse macrophages. (C) Chrysin upregulated the expression of LC3B mRNA level after stimulation with HG in a concentration-dependent manner. (D) Time-dependent effects of treatment with chrysin (10−6M) on LC3B protein presentation in the HG-cultured mouse macrophages. *P < 0.05 versus control group (three iterations per experiment, N = 4). Fig. 2Molecular regulation of chrysin on miR-204-5p and LC3B in hyperglycemic macrophage cultures. (A) Treatment with chrysin (10−6M), rapamycin (an autophagy inducer) and mutant miR-204-5p augmented LC3B mRNA levels and protein (B) in the HG-cultured macrophages for 6 h, however, by treating with wild-type miR-204-5p or 3-MA (an autophagy inhibitor) decreased LC3B protein. *P < 0.05 versus control group (three iterations per experiment, N = 4). Molecular regulation of chrysin on miR-204-5p and LC3B in hyperglycemic macrophage cultures. (A) Treatment with chrysin (10−6M), rapamycin (an autophagy inducer) and mutant miR-204-5p augmented LC3B mRNA levels and protein (B) in the HG-cultured macrophages for 6 h, however, by treating with wild-type miR-204-5p or 3-MA (an autophagy inhibitor) decreased LC3B protein. *P < 0.05 versus control group (three iterations per experiment, N = 4). Fig. 3Effect of miR-204-5p and chrysin on the luciferase activity of LC3B in macrophages under hyperglycemic stress conditions. The upper panel demonstrates the sequence of the mouse LC3B 3′UTR target site for miR-204-5p binding, which is located on the LC3B 3′UTR (387 to 408 bp). The lower panel demonstrates LC3B 3′UTR luciferase activity under HG stimulation conditions with chrysin (10−6M) and wild-type miR-204-5p treatment. (three iterations per experiment, N = 3). Effect of miR-204-5p and chrysin on the luciferase activity of LC3B in macrophages under hyperglycemic stress conditions. The upper panel demonstrates the sequence of the mouse LC3B 3′UTR target site for miR-204-5p binding, which is located on the LC3B 3′UTR (387 to 408 bp). The lower panel demonstrates LC3B 3′UTR luciferase activity under HG stimulation conditions with chrysin (10−6M) and wild-type miR-204-5p treatment. (three iterations per experiment, N = 3). Fig. 4Molecular regulatory effects of chrysin on miR-204-5p and LC3B in STZ-induced hyperglycemic rats. (A) The upper panel demonstrates blood glucose levels after STZ treatment (60–120 mg/kg), and the lower panel demonstrates the effect of chrysin (100 mg/kg) on STZ (90 mg/kg)-induced hyperglycemia. STZ-stimulated hyperglycemia present with different doses. Chrysin significantly reduced the levels of glucose (lower panel). (B) Quantitative real-time PCR analysis of miR-204-5p levels in arterial tissue after STZ-induced diabetes or combination STZ-induction with carotid artery balloon injury for different periods. (C) Quantitative real-time PCR analysis of miR-204-5p and LC3B mRNA levels in arterial tissue after carotid artery balloon injury in STZ-induced diabetic rats for different periods. (D) Real-time PCR analysis of LC3B mRNA levels in arterial tissue after carotid artery balloon injury. Treatment with chrysin (100 mg/kg) and wide-type miR-204-5p decreased the levels of LC3B in diabetic rats. (E) Western blotting of the suppressive effects of chrysin (100 mg/kg) and wide-type miR-204-5p on LC3B protein expression in macrophages from STZ-stimulated rats after 14 days of carotid artery balloon injury. *P < 0.05 versus hyperglycemia-induced group (three iterations per experiment, N = 4). #P < 0.05 versus sham group (three iterations per experiment, N = 4). Molecular regulatory effects of chrysin on miR-204-5p and LC3B in STZ-induced hyperglycemic rats. (A) The upper panel demonstrates blood glucose levels after STZ treatment (60–120 mg/kg), and the lower panel demonstrates the effect of chrysin (100 mg/kg) on STZ (90 mg/kg)-induced hyperglycemia. STZ-stimulated hyperglycemia present with different doses. Chrysin significantly reduced the levels of glucose (lower panel). (B) Quantitative real-time PCR analysis of miR-204-5p levels in arterial tissue after STZ-induced diabetes or combination STZ-induction with carotid artery balloon injury for different periods. (C) Quantitative real-time PCR analysis of miR-204-5p and LC3B mRNA levels in arterial tissue after carotid artery balloon injury in STZ-induced diabetic rats for different periods. (D) Real-time PCR analysis of LC3B mRNA levels in arterial tissue after carotid artery balloon injury. Treatment with chrysin (100 mg/kg) and wide-type miR-204-5p decreased the levels of LC3B in diabetic rats. (E) Western blotting of the suppressive effects of chrysin (100 mg/kg) and wide-type miR-204-5p on LC3B protein expression in macrophages from STZ-stimulated rats after 14 days of carotid artery balloon injury. *P < 0.05 versus hyperglycemia-induced group (three iterations per experiment, N = 4). #P < 0.05 versus sham group (three iterations per experiment, N = 4). Fig. 5Measurement of neointimal formation and lumen sizes and immunohistochemical staining of LC3B for the effects of chrysin and miR-204-5p in STZ-induced rats. (A) Significantly increased immunoreactive signals were observed in LC3B after 14 days of balloon injury. The left panel displays a cross section of the aorta, stained with hematoxylin, after treatment with chrysin (100 mg/kg), or miR-204-5p. The two right panels display double-staining results for LC3B (green) and DAPI (green, indicated by arrow) with macrophage labeling (red). (B) Quantitative analysis of cross-sectional lumen sizes; treatment with chrysin, or miR-204-5p significantly increased the lumen sizes (upper panel) but mildly mitigated the neointimal formations (lower panel) after 14 days of balloon injury. (C) At the intimal layer, the results of immunohistochemical staining and immunofluorescent analysis strongly indicated increased the LC3B expression in the rat carotid artery of hyperglycemia stress after 14 days of balloon injury. (D) Representative of M1/M2 polarization treated with chrysin in the carotid artery of STZ-induced rats after 14 days of balloon injury under immunofluorescent analysis. CD86 markers indicated M1 polarized macrophages, CD163 indicated M2 polarized macrophages. *P < 0.05 versus diabetes mellitus group. **P = 0.05 versus diabetes mellitus group. (three iterations per experiment, N = 5). Measurement of neointimal formation and lumen sizes and immunohistochemical staining of LC3B for the effects of chrysin and miR-204-5p in STZ-induced rats. (A) Significantly increased immunoreactive signals were observed in LC3B after 14 days of balloon injury. The left panel displays a cross section of the aorta, stained with hematoxylin, after treatment with chrysin (100 mg/kg), or miR-204-5p. The two right panels display double-staining results for LC3B (green) and DAPI (green, indicated by arrow) with macrophage labeling (red). (B) Quantitative analysis of cross-sectional lumen sizes; treatment with chrysin, or miR-204-5p significantly increased the lumen sizes (upper panel) but mildly mitigated the neointimal formations (lower panel) after 14 days of balloon injury. (C) At the intimal layer, the results of immunohistochemical staining and immunofluorescent analysis strongly indicated increased the LC3B expression in the rat carotid artery of hyperglycemia stress after 14 days of balloon injury. (D) Representative of M1/M2 polarization treated with chrysin in the carotid artery of STZ-induced rats after 14 days of balloon injury under immunofluorescent analysis. CD86 markers indicated M1 polarized macrophages, CD163 indicated M2 polarized macrophages. *P < 0.05 versus diabetes mellitus group. **P = 0.05 versus diabetes mellitus group. (three iterations per experiment, N = 5). In an observational study, Wang et al.38 reported that patients with lower circulating miR-204 levels were at high risk of cardiovascular diseases. Szydelko and Matyjaszek-Matuszek39 reported that miR-204 attenuated the phenotypic switch of aortic vascular smooth muscle cell in diabetic rat models. In our previous study, we found that chrysin ameliorated the neointimal formation by upregulating KLF2 expression through suppression of endothelial cell-derived exosomal microRNA-92a in the model of atheroprotection13. Wu et al.40 reported that Artemisia leaf extract ameliorated impaired motor function and rescued TH+ neurons in the substantia nigra pars compacta (SNpc) region in Parkison’s rat model; similar to the results of the in vitro study, TRPML1, LC3B, and β-catenin expression was enhanced. Notably, treatment with chrysin revealed the different presentation the LC3B mRNA in our in vitro and in vivo models, we suggested that LC3B macrophage autophagy played the role in diabetic atherosclerosis; meanwhile, treatment with chrysin indicates that the LC3B autophagy maker exerts the upregulated expression in vitro, but reversed condition in vivo models. The miR-204-5p revealed the similar decreasing tendency in two models. This phenomenon proposed that the potential mechanisms was regulated through the interaction inflammatory cytokine with LC3B autophagy in diabetic cardiovascular diseases. Sousa et al.41 reported that the LC3b and beclin-1 expression were increased in non-diabetic-bone marrow-derived macrophages (ND-BMDM) due to the normal cellular regulatory process in response to stress caused by the hyperglycemic condition and increased IL-6 and TNF-α levels within 24 h, proposed that the impaired autophagic macrophages were reinforced and sensitized under hyperglycemic stress in diabetic-derived rats; reversed LC3b expression in D-BMDMs stimulated and in hyperglycemic conditions. These findings of LC3B expression were speculated about the short-term or non-short-term regulation of the activated and recruited inflammatory reaction in vitro and in vivo models. However, the inflammatory regulating effect of mechanism on plant-derived microRNAs and autophagy needs the further investigation. In conclusion, to the best of our knowledge, our study reveals that chrysin plays a functional role in macrophage autophagy, suggesting in promising role in the treatment of patients with diabetes in further in vivo studies. Despite our study limitations, our current and previous findings confirm the atheroprotective effects of chrysin, indicating its potential value in the prevention of diabetic CVDs. Overall, the protective effects of chrysin against diabetic atherosclerosis are associated with its the molecular regulatory effects on macrophage autophagy, which ameliorated neointimal hyperplasia. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1 Supplementary Material 2 Supplementary Material 2 Supplementary Material 1 Supplementary Material 1 Supplementary Material 2 Supplementary Material 2 Supplementary Material 3 Supplementary Material 3 Supplementary Material 4 Supplementary Material 4 Supplementary Material 5 Supplementary Material 5 Supplementary Material 6 Supplementary Material 6 Supplementary Material 9 Supplementary Material 9